A detailed history of Prudential Financial Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 97,685 shares of AUPH stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
97,685
Previous 164,230 40.52%
Holding current value
$1.5 Million
Previous $1.39 Million 22.43%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$7.47 - $13.14 $497,091 - $874,401
-66,545 Reduced 40.52%
97,685 $1.08 Million
Q2 2025

Aug 12, 2025

BUY
$7.2 - $8.64 $30,240 - $36,288
4,200 Added 2.62%
164,230 $1.39 Million
Q1 2025

May 13, 2025

BUY
$7.55 - $8.77 $1.21 Million - $1.4 Million
160,030 New
160,030 $1.29 Million
Q2 2023

Aug 11, 2023

BUY
$8.96 - $11.69 $2.17 Million - $2.83 Million
241,740 New
241,740 $2.34 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $2.18B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.